MICAL2 prostate cancer variants (MICAL2-PV) are found to be overexpressed in prostate cancer, and the protein expression of MICAL2-PV is associated with prognosis in patients with colorectal cancer (46). Here, MICAL2 is linked to prostate carcinoma.